ICD-11HA20

SEXUAL PAIN-PENETRATION DISORDER (VAGINISMUS)

Sexual pain-penetration disorder
ICD-10F52.5Nonorganic vaginismus
DSM-5-TRF52.6Genito-Pelvic Pain/Penetration Disorder

1. Definition and nosology

Genito-pelvic pain / penetration disorder (ICD-11: HA20; DSM-5-TR Genito-Pelvic Pain/Penetration Disorder F52.6) — during penetration attempts: (a) difficulty, (b) genital or pelvic pain, (c) fear of pain, (d) tension of pelvic floor muscles. Classic vaginismus and dyspareunia are combined in this entity.

Duration ≥ 6 months; lifelong or acquired.

2. History

  • Sims J.M. (1861) — description of vaginismus.
  • Masters & Johnson (1970) — pelvic floor tension.
  • DSM-5 (2013) — vaginismus and dyspareunia combined into GPPPD.
  • ISSWSH and ACOG guidelines.

3. Epidemiology

  • Prevalence in women is 5–17% (in clinical and non-clinical samples).
  • Lifelong vaginismus — in young women, at first penetration attempt.
  • Acquired — trauma, infection, atrophic vaginitis, post-surgery.

4. Aetiology and pathogenesis

  • Biological — atrophic vaginitis (postmenopausal), vulvodynia, endometriosis, infection, surgical wound.
  • Psychological — sexual trauma, anxiety, abstinence education, fear of pain.
  • Relationship and partner factors.

5. Clinical features

  • Reflexive tension of pelvic floor muscles during penetration.
  • Pain (burning, stabbing).
  • Penetration avoidance.
  • Gynecological examination also difficult or impossible.

6. Diagnosis

6.1 Unified diagnostic criteria (DSM-5-TR)

A. At least one of the following:

  • Difficulty in penetration;
  • Pain in vulvovaginal or pelvic region during or attempted penetration.
  • Fear of pain associated with anticipation of penetration.
  • In attempted penetration, tension of the pelvic floor muscles.

B. Duration ≥ 6 months.

C. Distress.

6.2 Source-specific clarifications

  • ISSWSH and ACOG.

6.3 Diagnostic algorithm

  1. Clinical interview (sexual history, pain characteristics, trauma).
  2. Careful gynecological examination — with caution, with patient consent.
  3. Vulvodynia screening (Q-type test).
  4. Infection, atrophic vaginitis, exception endometriosis.
  5. Pelvic floor assessment.

6.4 Differential diagnosis

ConditionDistinguishing feature
VulvodyniaLocalized vulvar pain, Q-type positive.
Atrophic vaginitisPostmenopausal, estrogen deficiency.
EndometriosisDeep dyspareunia, dysmenorrhoea.
Infection (candida, vaginosis)Exudation, microbiological.

7. Examination and assessment

  • Gynecological examination.
  • Pelvic floor assessment.
  • FSFI; pain scales.

8. Treatment

  1. Multidisciplinary approach — pelvic floor physiotherapy + CBT + education.
  2. Pelvic Floor Physiotherapy — biofeedback, manual therapy, dilator therapy (gradual size increase).
  3. CBT and exposure therapy — fear of pain and avoidance; ter Kuile M.M. RCT.
  4. Sensate focus and couple therapy.
  5. Topical anesthetic (lidocaine) — in provoked vulvodynia (Goldstein A.T.).
  6. Local estrogen for atrophic vaginitis.
  7. Botulinum toxin A — in refractory vaginismus; evidence base is growing.
  8. Antidepressant/anticonvulsant (amitriptyline, gabapentin) — for neuropathic component.

Source-specific specifications

  • ter Kuile M.M. et al. CBT vaginismus.
  • Goldstein A.T. et al. ISSWSH vulvodynia consensus.

Treatment methods

  1. Dilator Therapy — Gradual increase in size; combined with relaxation.
  2. Pelvic Floor Physiotherapy — Biofeedback, manual therapy.
  3. CBT/Exposure — Fear of pain and avoidance.
  4. Topical Estrogen — Atrophic vaginitis.
  5. Botox (off-label) — For refractory vaginismus; selective.

9. Prognosis

With a multidisciplinary approach, prognosis is good (70–90%); in refractory cases, botox or intensive psychological intervention.

10. Myths and misconceptions

Myth 1: “Vaginismus is an emotional rejection of the partner”

Evidence: Reflex muscle tension — outside conscious control; accusing harmful.

Myth 2: “Vaginismus cannot be treated”

Evidence: CBT + dilator + physiotherapy combination 70–90% efficacy; ter Kuile RCTs.

Myth 3: “Treatment should be done to increase penetration frequency”

Evidence: target is reducing patient distress, restoring sense of control and choice; not a performance indicator.

Myth 4: “Local anesthetic is effective for all sexual pain”

Evidence: Effective in provoked vulvodynia; use limited in generalized vaginismus — main problem is muscle tension.

Myth 5: “Forcing ‘compulsory exercise’ helps with penetration attempts”

Evidence: urgent, painful repetition increases avoidance and fear; gradual, controlled exposure effective.

11. Sources

  1. WHO. ICD-11. HA20 Genito-pelvic pain/penetration disorder. 2024.
  2. APA. DSM-5-TR. 2022.
  3. Ter Kuile M.M. et al. Therapist-aided exposure for women with lifelong vaginismus: a RCT. J Consult Clin Psychol 2013;81(6):1127–1136.
  4. Goldstein A.T. et al. Vulvodynia: Assessment and Treatment. J Sex Med 2016;13(4):572–590.
  5. Bergeron S. et al. Genital pain in women and men: It can hurt more than your sex life. Sex Med Rev 2020.

Order the book

The book is being prepared for print publication. If you would like to be among the first readers, leave your details — we will contact you as soon as it is published.